Two years ago i looked at potential nominal prices at retail using existing products already accepted in the marketplace, i.ei. A competitive comparison if you will. The details are now lost, but suffice it to say that a retail price of $60 for a three day patch will see them flying out the door.
A more agressive retail for a 3 day patch could be $100 plus and still sell well.
Flying today and tomorrow, but will reconstruct the data when i can. Needless to say, there is considerable profit potential here.
- Forums
- ASX - By Stock
- AVE
- transdermal vs oral opioid treatment
transdermal vs oral opioid treatment, page-2
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 40962233 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 39708472 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 40962233 | 0.002 |
32 | 75717741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 39705430 | 30 |
0.004 | 30346565 | 17 |
0.005 | 10575266 | 9 |
0.006 | 10908952 | 10 |
0.007 | 13396103 | 7 |
Last trade - 10.31am 15/11/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
Day chart unavailable
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
SPONSORED BY The Market Online